EVEXIAS® Health Solutions, LLC., headquartered in Southlake, Texas and founded in 2018 by Dr. Terri DeNeui, DNP, and CEO Dan DeNeui, is redefining the standard for personalized, integrative healthcare. Our mission is clear: restore balance and vitality through innovative therapies that treat the whole person, not just symptoms.
Guided by integrity, innovation, compassion, and empowerment, EVEXIAS envisions a proactive, personalized healthcare system rooted in lasting human connection. We are a national leader in advanced hormone replacement therapy and integrative wellness solutions, partnering with providers across the U.S. while also engaging directly with patients. This dual focus empowers clinicians with evidence-based tools and inspires patients to take ownership of their health.
Our portfolio spans precision hormone replacement therapy (HRT), peptide therapeutics, and advanced nutraceuticals—each designed to optimize patient outcomes and support practice growth. At the heart of these innovations is The EvexiPEL Method, a proprietary approach that goes beyond traditional HRT. Using patented, bioidentical hormone pellets inserted beneath the skin, The EvexiPEL Method delivers consistent, time-released doses over 3–6 months, mimicking the body’s natural rhythms for balanced, long-lasting relief.
Backed by thousands of provider partnerships nationwide, EVEXIAS has achieved remarkable growth and credibility as a trusted voice in integrative medicine. Looking ahead, we remain committed to supporting practitioners, patients, and communities through innovation, education, and investment. More than a healthcare company, EVEXIAS is a catalyst for change in how health, vitality, and longevity are achieved.